Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1980-06-23
1982-06-01
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
23230B, 260112B, 424 12, 424 85, G01N 3356, G01N 3358, C07G 700
Patent
active
043327877
ABSTRACT:
Body fluids are assayed for aryloxypropylamine beta-adrenergic antagonists and/or their active metabolites by agglutination reaction with antibody for the antagonist and/or active metabolite. The antibody is produced from an antigen comprising a conjugate of an immunogenic protein linked by a diazo moiety to an aryloxypropylamine beta-adrenergic antagonist.
REFERENCES:
patent: 4026879 (1977-05-01), Spector
patent: 4070492 (1978-01-01), Spector
Mueller et al., From Radio Immunoassay of Drugs and Hormones in Cardiovascular Medicine, Ed. Albertine et al., Elsevier/North-Holland, The Netherlands, 1979, pp. 93-106.
Haber Edgar
Homcy Charles J.
Cook Paul J.
Guthrie Marvin C.
Nucker Christine M.
The Massachusetts General Hospital
LandOfFree
Assay for beta-adrenergic antagonists and antibody therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Assay for beta-adrenergic antagonists and antibody therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Assay for beta-adrenergic antagonists and antibody therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1849403